用于多发性硬化皮质病灶识别的临床可行7-Tesla方案
本研究评估7-T MRI扫描仪在适合临床研究的时间与解剖覆盖范围内识别多发性硬化患者皮质病灶的能力,并检验灰质病灶与临床评分的相关性。40例患者中35/40(87.5%)检出皮质病灶,3D-T1加权与T2*加权序列检出率高度相关(r=0.99,p<0.001),读者间一致性高(ICC≥0.995),皮质病灶与运动和认知评分显著相关(均p≤0.04)。作者建议3D-T1加权容积可用于超高场MRI评估多发性硬化皮质病灶。
要点
- 7-T MRI 3D-T1加权容积可在临床可行时间内全脑识别多发性硬化皮质病灶。
- 3D-T1加权与T2*加权序列皮质病灶检出率高度相关(r=0.99,p<0.001)。
- 皮质病灶与运动和认知评分显著相关(均p≤0.04)。
核心结论
- 在7-T下使用临床可行时间采集的3D-T1加权容积可在全脑识别多发性硬化皮质病灶,性能与T2*加权序列相当。
- 基于皮质病灶在临床残疾发展中的核心作用,作者建议3D-T1加权容积可在超高场扫描仪MRI评估多发性硬化皮质病灶中发挥作用。
研究设计与样本
- 本研究为评估7-T MRI序列识别多发性硬化皮质病灶能力的研究,纳入40例多发性硬化患者(男/女,17/23;44.7±12.6岁)。
- 7-T MRI方案包括3D-T1加权和T2*加权序列,由三位不同经验的读者独立评估并记录皮质病灶数量。
- 读者间一致性采用组内相关系数(ICC)评估,序列间皮质病灶检出比较采用Lin一致性相关系数,皮质病灶与临床数据关系采用偏相关和多变量回归模型分析。
关键影像表现/征象
- 35/40例(87.5%)受试者检出皮质病灶。
- 3D-T1加权图像皮质病灶检出率与T2*加权图像检出率显著相关(r=0.99;p<0.001),读者间一致性高(ICC≥0.995)。
- 皮质病灶与运动和认知评分均显著相关(均p≤0.04)。
临床应用与阅片要点
- 作者建议3D-T1加权容积可在超高场扫描仪MRI评估多发性硬化皮质病灶中发挥作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to evaluate the capability of sequences acquired on a 7-T MRI scanner, within times and anatomical coverage appropriate for clinical studies, to identify cortical lesions (CLs) in patients with Multiple Sclerosis (MS). Furthermore, we aimed to confirm the clinical significance of CL, testing the correlations between gray matter (GM) lesions and clinical scores.
METHODS: A 7-T MRI protocol included 3D-T1-weighted and T2*-weighted sequences. Images were evaluated independently by three readers of different experience, and the number of CLs was recorded. Between-rater concordance was assessed calculating the intraclass correlation coefficient (ICC). Lin's concordance correlation coefficient was used to compare CL detection between sequences, while partial correlations and multivariable regression models were used to study the relationship between CL and clinical data.
RESULTS: Forty MS patients (M/F, 17/23; 44.7 ± 12.6 years) were enrolled in this study, and CLs were identified in 35/40 subjects (87.5%). CL detection rate on 3D-T1-weighted images was significantly correlated with the detection rate on T2*-weighted images (r = 0.99; p < 0.001), with high concordance between readers (ICC ≥ 0.995). CLs were significantly correlated with both motor and cognitive scores (all with p ≤ 0.04).
CONCLUSIONS: CL can be identified over the whole brain at 7-T in MS using a 3D-T1-weighted volume, acquired in a clinically feasible time and with comparable performance to that achievable using the T2*-weighted sequence. Based on the central role of CL in the development of clinical disability, we suggest that 3D-T1-weighted volume may play a role in the evaluation of CL in MS undergoing MRI on ultra-high-field scanners.
KEY POINTS: • Cortical lesions can be identified in a clinically feasible time with a 7-T protocol, which includes a 3D-T1-weighted volume. • Cortical lesions correlated significantly with both motor and cognitive disability in MS patients. • Given their correlation with clinical disability, evaluation of a cortical lesion on a 7-T clinical protocol could help in the management of MS patients.
引用
- Cocozza S, Cosottini M, Signori A, et al. A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis. Eur Radiol. 2020. PMID: 32211962. doi:10.1007/s00330-020-06803-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。